Mark Lewis shared on X/Twitter:
“Prophylactic gastrectomy is BRUTAL.
We have to be so careful recommending it in ‘likely’ pathogenic CDH1 (or CTNNA1) variants.”
Visit the article website.
Source: Mark Lewis/X
Mark A. Lewis is the Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, the Co-Chair of adolescent & young adult (AYA) oncology in the SWOG cooperative group, and the Vice President of American Multiple Endocrine Neoplasia Support. Dr. Lewis is also a well-known patient advocate and social media influencer.